THERMO FISHER SCIENTIFIC POWDER US HOLDINGS LIMITED
Get an alert when THERMO FISHER SCIENTIFIC POWDER US HOLDINGS LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
—
Latest balance sheet
Net assets
£1.8B
USD 2,470,736,000
-47.3% lowest in 3 filed years
Employees
—
Average over period
Profit before tax
-£1.7B
USD -2,214,162,000
-108% lowest in 3 filed years
Net assets
3-year trend · vs Unclassified median
Accounts
3-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 | Δ vs prior |
|---|---|---|---|---|---|
| Turnover | — | — | — | — | |
| Operating profit | -£12,726 | -£20,075,299,446 | -£1,222,712,232 | +93.9% | |
| Profit before tax | -£583,501,273 | £20,814,889,954 | -£1,657,555,023 | -108% | |
| Net profit | -£583,501,273 | £739,590,508 | -£1,657,555,023 | -324.1% | |
| Cash | — | — | — | — | |
| Total assets less current liabilities | £25,883,522,234 | £10,571,805,660 | £8,914,250,636 | -15.7% | |
| Net assets | £15,450,134,002 | £3,507,185,207 | £1,849,630,184 | -47.3% | |
| Equity | £15,450,134,002 | £3,507,185,207 | £1,849,630,184 | -47.3% | |
| Average employees | — | — | — | — | |
| Wages | — | — | — | — | |
| Directors' remuneration | — | — | — | — |
Figures converted to GBP from USD at 0.749 per USD (Frankfurter spot rate) — hover any figure for the original. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Return on capital employed | -0.0% | -189.9% | -13.7% | |
| Current ratio | 0.00x | 0.00x | 0.00x | |
| Interest cover | -0.00x | -30.73x | -2.81x |
Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Mitchell Charlesworth (Audit) Limited
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate. Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.”
Group structure
- THERMO FISHER SCIENTIFIC POWDER US HOLDINGS LIMITED · parent
- Wildcat Acquisition Holdings (UK) Limited 100%
- Clinical Technology Centre (International) Limited 100%
- Clinical Technology Centre (Ireland) Limited 100%
- Excel PharmaStudies, Inc. 100%
- Greenbird Limited 100%
- Limited Liability Company Contract Research Organisation Innopharm - Ukraine 100%
- Limited Liability Company PPD Development (Smolensk) 100%
- LLC PPD Ukraine 100%
- Medical Centre Synexus Sofia EOOD 100%
- Medimix Latam Pesquisa de Mercado Ltda 100%
- Pharmaceutical Product Development OÜ 100%
- Pharmaceutical Product Development South Africa (Proprietary) Limited - Uganda Branch 100%
- Pharmaceutical Product Development South Africa (Proprietary) Ltd 100%
- Pharmaceutical Product Development Spain SL 99.24%
- PPD (Netherlands) B.V. 100%
- PPD (Netherlands) LLC 100%
- PPD Argentina S.A. 95%
- PPD Australia Pty Limited 100%
- PPD Bulgaria EOOD 100%
- PPD Canada, Ltd. 100%
- PPD Colombia S.A.S 100%
- PPD Czech Republic S.R.O. 100%
- PPD Denmark, Filial af PPD Scandinavia AB, Sverige 100%
- PPD Development (HK) Limited 50%
- PPD Development (HK) Limited - Taiwan Branch 50%
- PPD Development (S) Pte. Ltd - Indonesia 100%
- PPD Development (S) Pte. Ltd. 100%
- PPD Development (S) Pte. Ltd. - Malaysia branch 100%
- PPD Development (S) Pte. Ltd. (Philippines Branch) 100%
- PPD Development (S) Pte. Ltd. Korea Branch 100%
- PPD Development (Thailand) Co., Ltd 100%
- PPD Development Ireland Limited 100%
- PPD do Brasil- Suporte a Pesquisa Clinica Ltda. 100%
- PPD France SAS 100%
- PPD Georgia LLC 100%
- PPD Germany GmbH 100%
- PPD Germany GmbH & Co. KG 100%
- PPD Global Central Labs (S) Pte. Ltd. 100%
- PPD Global Limited - Ghana Branch 100%
- PPD Global Limited - Kenya Branch 100%
- PPD Global Limited - New Zealand Branch 100%
- PPD Global Limited Merkezi Ingiltere Turkiye Istanbul Subesi 100%
- PPD Global Limited Sucursal em Portugal 100%
- PPD Global Ltd - Austria Branch 100%
- PPD Global Ltd - Greece Branch 100%
- PPD Global Ltd. 100%
- PPD Hrvatska d.o.o. 100%
- PPD International Holdings (UK) Ltd 100%
- PPD International Holdings GmbH 100%
- PPD International Holdings, Inc. y Compania Limitada 99%
- PPD International Holdings, LLC 100%
- PPD International Holdings, LLC - Belgium Branch 100%
- PPD International Investments Limited 100%
- PPD Italy S.r.l 100%
- PPD Latvia SIA 100%
- PPD Magyarország Kutatási és Fejlesztési Kft 100%
- PPD Mexico S.A. de C.V. 100%
- PPD Netherlands International LLC 100%
- PPD Panama, S. DE. R.L. 100%
- PPD Peru S.A.C. 100%
- PPD Pharmaceutical Development Vietnam Company Limited 100%
- PPD Poland sp. z o.o. 100%
- PPD Research, razvoj farmacevtskih izdelkov, d.o.o 100%
- PPD Romania SRL 100%
- PPD Scandinavia AB 100%
- PPD Scandinavia AB NUF 100%
- PPD Serbia D.O.O. Beograd 100%
- PPD Slovak Republic s.r.o. 100%
- PPD UK Holdings Limited 100%
- PPD-SNBL K.K. 60%
- Shorecloud Corporation 99.98%
- Synexus Bulgaria EOOD 100%
- Synexus Clinical Research Acquisitions Limited 100%
- Synexus Clinical Research GmbH 100%
- Synexus Clinical Research Limited 100%
- Synexus Clinical Research Midco No1 Limited 100%
- Synexus Clinical Research South Africa (Pty) Limited 100%
- Synexus Czech s.r.o. 100%
- Synexus Limited 100%
- SYNEXUS Magyarország Egészségügyi Szolgáltató Korlátolt Felelősségű Társaság 100%
- Synexus Polska sp. z o.o. 100%
- Synexus Ukraine Limited Liability Company 100%
- The Resident Representative Office of PPD Development (S) Pte. Ltd. in Ho Chi Minh City 100%
- Thermo Fisher Scientific BLG Limited 100%
- Thermo Fisher Scientific PN3 LLC 100%
- Thermo Fisher Scientific Powder US Holdings LLC 100%
- Thermo Fisher Scientific Powder US Limited 100%
- Thermo Fisher Scientific PR Limited 100%
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
6 active · 2 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| OAKWOOD CORPORATE SECRETARY LIMITED | Corporate Secretary | 2021-10-22 | — | — |
| AHMED, Syed Waqas | Director | 2021-10-22 | Nov 1979 | British |
| CAMERON, Euan Daney Ross | Director | 2021-10-22 | Mar 1976 | British |
| GREEN, Georgina Adams | Director | 2024-04-18 | Mar 1970 | British |
| SMITH, Anthony Hugh | Director | 2021-10-22 | May 1962 | American |
| STARR, Alison Jane | Director | 2024-04-18 | Jan 1977 | British |
Show 2 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| GREGG, Rhona | Secretary | 2021-10-22 | 2026-03-31 |
| NORMAN, David John | Director | 2021-10-22 | 2024-04-18 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Thermo Fisher Scientific Powder Uk Senior Holdings Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2023-11-17 | Active |
| Thermo Fisher Scientific Inc. | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2021-10-22 | Ceased 2023-11-17 |
Filing timeline
Last 20 of 46 total filings
Material constitutional events — rename, articles re-file, resolution
- 2024-12-09 RESOLUTIONS Resolution
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-06-18 | AA | accounts | Accounts with accounts type full | |
| 2026-04-01 | TM02 | officers | Termination secretary company with name termination date | |
| 2026-02-16 | SH01 | capital | Capital allotment shares | |
| 2025-10-30 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-06-09 | AA | accounts | Accounts with accounts type full | |
| 2024-12-09 | SH20 | capital | Legacy | |
| 2024-12-09 | SH19 | capital | Capital statement capital company with date currency figure | |
| 2024-12-09 | CAP-SS | insolvency | Legacy | |
| 2024-12-09 | RESOLUTIONS | resolution | Resolution | |
| 2024-11-06 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2024-11-05 | SH01 | capital | Capital allotment shares | |
| 2024-06-07 | AA | accounts | Accounts with accounts type full | |
| 2024-04-23 | AP01 | officers | Appoint person director company with name date | |
| 2024-04-19 | AP01 | officers | Appoint person director company with name date | |
| 2024-04-19 | TM01 | officers | Termination director company with name termination date | |
| 2024-03-06 | SH01 | capital | Capital allotment shares | |
| 2024-02-08 | PSC02 | persons-with-significant-control | Notification of a person with significant control | |
| 2024-02-08 | PSC07 | persons-with-significant-control | Cessation of a person with significant control | |
| 2023-12-07 | SH01 | capital | Capital allotment shares | |
| 2023-10-23 | CS01 | confirmation-statement | Confirmation statement with updates |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 4
- Capital events
- 4
- Officers appointed
- 0
- Officers resigned
- 1
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.